Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 32 Records) |
| Query Trace: Neoplasms and DDR2[original query] |
|---|
| Genetic profiling of thymic carcinoma using targeted next-generation sequencing. Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 174-9. Shitara Masayuki, Okuda Katsuhiro, Suzuki Ayumi, Tatematsu Tsutomu, Hikosaka Yu, Moriyama Satoru, Sasaki Hidefumi, Fujii Yoshitaka, Yano Moto |
| Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer. Medical oncology (Northwood, London, England) 2014 Oct 31 (10): 176. Nico? Marcin, Powrózek Tomasz, Krawczyk Pawe?, Jarosz Bo?ena, Paj?k Beata, Sawicki Marek, Kucharczyk Krzysztof, Trojanowski Tomasz, Milanowski Janu |
| Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Feb 21 (3): 632-41. Seiwert Tanguy Y, Zuo Zhixiang, Keck Michaela K, Khattri Arun, Pedamallu Chandra S, Stricker Thomas, Brown Christopher, Pugh Trevor J, Stojanov Petar, Cho Juok, Lawrence Michael S, Getz Gad, Brägelmann Johannes, DeBoer Rebecca, Weichselbaum Ralph R, Langerman Alexander, Portugal Louis, Blair Elizabeth, Stenson Kerstin, Lingen Mark W, Cohen Ezra E W, Vokes Everett E, White Kevin P, Hammerman Peter |
| Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients. Molecular and clinical oncology 2014 Sep 2 (5): 714-718. Yashima Hideaki, Shimizu Kimihiro, Araki Takuya, Aomori Tohru, Ohtaki Yoichi, Nagashima Toshiteru, Enokida Yasuaki, Atsumi Jun, Nakamura Tomonori, Takeyoshi Izumi, Yamamoto Koujir |
| Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients. BMC cancer 2014 14 (1): 369. Miao Liyun, Wang Yongsheng, Zhu Suhua, Shi Minke, Li Yan, Ding Jingjing, Yang Jun, Ye Qing, Cai Hourong, Zhang Deping, Liu Hongbing, Song Yo |
| Racial diversity of actionable mutations in non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Feb 10 (2): 250-5. Bollig-Fischer Aliccia, Chen Wei, Gadgeel Shirish M, Wenzlaff Angela S, Cote Michele L, Schwartz Ann G, Bepler Gero |
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC cancer 2014 14 786. Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy. Oncology research and treatment 2015 38 (11): 560-9. Gautschi Oliver, Stadelmann Carola, Aebersold-Keller Franziska, König Katharina, Büttner Reinhard, Heukamp Lukas C, Betticher Daniel, Baumann Christa, Buser Katharina, Calderoni Antonello, Casty Adrian, D?Addario Giannicola, Irlé Claudius, Mamot Christoph, Morant Rudolf, Trojan Andreas, Pellicioli Erica, Jehle-Schwertfeger Sonja, Aebi Stefan, Diebold Joach |
| Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). Oncotarget 2016 Apr . Lim Sun Min, Kim Hye Ryun, Cho Eun Kyung, Min Young Joo, Ahn Jin Seok, Ahn Myung-Ju, Park Keunchil, Cho Byoung Chul, Lee Ji-Hyun, Jeong Hye Cheol, Kim Eun Kyung, Kim Joo-Ha |
| Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 Feb . Nico? M, Krawczyk P, Jarosz B, Sawicki M, Michnar M, Trojanowski T, Milanowski |
| DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer. Anticancer research 2017 05 37 (5): 2587-2591. Sasaki Shin, Ueda Masami, Iguchi Tomohiro, Kaneko Manabu, Nakayama Hiroshi, Watanabe Toshiyuki, Sakamoto Atsuhiko, Mimori Kos |
| Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients. Cancer research and treatment : official journal of Korean Cancer Association 2017 Jan . Lee Mi-Sook, Jung Eun Ah, An Sung Bin, Kim Yu Jin, Oh Doo-Yi, Song Ji-Young, Um Sang-Won, Han Joungho, Choi Yoon- |
| Targeted therapy in nonsmall cell lung cancer. Indian journal of cancer 2017 12 54 (1): 83-88. Puri |
| Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing. Clinical lung cancer 2017 Oct . Ricordel Charles, Lespagnol Alexandra, Llamas-Gutierrez Francisco, de Tayrac Marie, Kerjouan Mallorie, Fievet Alice, Hamdi-Rozé Houda, Aliouat Amyrat, Desrues Benoit, Mosser Jean, Léna Her |
| Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 01 13 (1): 63-72. Tokaca Nadza, Barth Sarah, O'Brien Mary, Bhosle Jaishree, Fotiadis Nicos, Wotherspoon Andrew, Thompson Lisa, Popat Sanj |
| Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients. PloS one 2018 13 (7): e0200633. Fathi Zahra, Mousavi Seyed Ali Javad, Roudi Raheleh, Ghazi Farid |
| Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment. Oncotarget 2018 May 9 (40): 26195-26208. Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Grauslund Morten, Melchior Linea, Sørensen Jens Be |
| Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure. Journal of cancer prevention 2018 1 22 (4): 234-240. Choi Jung Ran, Koh Sang-Baek, Park Seong Yong, Kim Hye Run, Lee Hyojin, Kang Dae Ryo |
| Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature. Anticancer research 2019 Feb 39 (2): 847-852. Smolle Maria A, Kashofer Karl, Riedl Jakob M, Stotz Michael, Gerger Arm |
| Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease. Translational oncology 2019 12 13 (2): 245-253. Jing Wenjiang, Li Ling, Zhang Xiumei, Wu Shouxin, Zhao Jiangman, Hou Qunxing, Wu Haotian, Ma Wu, Li Shuheng, Liu Huimin, Yang Binh |
| Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients. International journal of clinical oncology 2019 1 24 (2): 141-152. Gao Xian Hua, Yu Guan Yu, Hong Yong Gang, Lian Wei, Chouhan Hanumant, Xu Yi, Liu Lian Jie, Bai Chen Guang, Zhang W |
| Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China. Clinical lung cancer 2020 Feb . Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh |
| Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study. Oncotarget 2020 2 11 (5): 550-559. Aramini Beatrice, Banchelli Federico, Bettelli Stefania, Manfredini Samantha, D'Amico Roberto, Masciale Valentina, Pinelli Massimo, Moretti Margherita, Stefani Alessandro, Bertolini Federica, Dominici Massimo, Morandi Uliano, Maiorana Antoni |
| Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1. Pathology, research and practice 2020 1 216 (2): 152797. Liu Junying, Liu Yuepi |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
| Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer medicine 2022 11 . Li Kai, Cao Li, Li Cheukfai, Wu Jundong, Chen Bo, Zhang Guochun, Li Xueri, Wen Lingzhu, Jia Minghan, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Mok Hsiaopei, Ren Chongyang, Wang Yulei, Qi Xiaofang, Guo Lijie, Che Yue, Liao Ni |
| Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis. Cancer research and treatment 2023 9 . Changhee Park, Rokhyun Kim, Jaeyong Choi, Miso Kim, Tae Min Kim, Ilkyu Han, Jong-Il Kim, Han-Soo K |
| Potentially functional variants of PARK7 and DDR2 in ferroptosis-related genes predict survival of non-small cell lung cancer patients. International journal of cancer 2024 9 . Huilin Wang, Hongliang Liu, Xiaozhun Tang, Guojun Lu, Sheng Luo, Mulong Du, David C Christiani, Qingyi W |
| Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 2024 4 8 e2300495. Hye Sook Kim, Jong Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon-Kuk Lee, Ji-Youn H |
- Page last reviewed:Feb 1, 2024
- Content source: